Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Manyawin Forte is a traditional Ayurvedic formulation developed and marketed by SKM Siddha and Ayurveda Company (India) Private Limited. Available as 650 mg soft gel capsules, the product contains a complex blend of herbal ingredients, including Rasna (*Alpinia galanga*), Shunti (*Zingiber officinale*), Guduchi (*Tinospora cordifolia*), Sahachara (*Barleria prionitis*), Mustha (*Cyperus rotundus*), and Shatavari (*Asparagus racemosus*). It is indicated for the treatment of various musculoskeletal disorders, including joint pain, inflammation, cervical spondylosis, and cervical injuries. The formulation works through broad anti-inflammatory mechanisms to reduce stiffness and swelling, promote blood circulation, and alleviate discomfort associated with the cervical spine and joints.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Manyawin Forte.